CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.
CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic ...
CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the ...
Mumbai, Dec 17: A 550-gram benign (non-cancerous) prostate was successfully removed from a 70-year-old patient using ...
The FDA previously granted marketing authorization for CMR’s first-generation Versius Surgical System through the De Novo ...
South Commons, Suite 145 In a dorm at Grove City College over a decade ago, Jake Loosararian built a robot. Today, he’s ...
The robots are powered by tiny microcomputers developed by David Blaauw and Dennis Sylvester, engineers at the University of ...
Sands Capital, an investment management company, released its “Sands Capital Global Growth Fund” third-quarter 2025 investor ...
The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...
Lifeward, a Marlborough-based medical device company, has expanded its global footprint, partnering with a Singapore-based ...
What Happened? Shares of medical tech company CONMED (NYSE:CNMD) jumped 3.3% in the afternoon session after positive ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its ...